Literature DB >> 15165615

Parenteral nutrition practices in hospital pharmacies in Switzerland, France, and Belgium.

N Maisonneuve1, C A Raguso, A Paoloni-Giacobino, S Mühlebach, O Corriol, J L Saubion, J D Hecq, A Bailly, M Berger, C Pichard.   

Abstract

OBJECTIVE: Important changes in administering total parenteral nutrition (PN) admixtures have occurred over the past decade. This study describes hospital pharmacists' practices in France (F), Switzerland (CH), and Belgium (B).
METHODS: From the responses received using a standardized questionnaire, (n = 378) we determined the origin, types of container used, and choice of PN formula (standard versus tailor-made) and the type of quality control and the existence of nutrition support teams.
RESULTS: The mean response rates were 55.6% (CH), 30.5% (F), and 24.5% (B). Standard formulas were used mainly for adult patients (CH, 86%; F, 79%; B, 86%), whereas approximately 50% of tailor-made PN bags were used for children. Single-compartment or multicompartment bags or glass bottles contained standard formulas. Most standard formulas were provided by industry, apart from (B), where 50% of PN solutions were compounded by hospital pharmacies. Single-compartment bags contained generally tailor-made formulas produced exclusively by hospital pharmacies in (CH) and (B), whereas 33% were provided by industry in (F). Quality controls were mostly visual and occurred in 75% to 95% of hospitals. Nutrition support teams were present in 32% to 45% of hospitals.
CONCLUSION: The choice, origin, and type of container used for PN formulas were highly variable among countries. However, the use of standard formulas in bags was predominant in (CH) and (B). The function of nutrition support teams was similar in (F), (CH), and (B).

Entities:  

Mesh:

Year:  2004        PMID: 15165615     DOI: 10.1016/j.nut.2004.03.020

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  8 in total

Review 1.  Parenteral nutrition: a call to action for harmonization of policies to increase patient safety.

Authors:  Valery Gallagher; David Berlana; Mattias Paulsson; Rebecca Jayne White
Journal:  Eur J Clin Nutr       Date:  2020-06-10       Impact factor: 4.016

2.  Assessment of implementation of a standardized parenteral formulation for early nutritional support of very preterm infants.

Authors:  Richard Lenclen; Sylvie Crauste-Manciet; Philippe Narcy; Saida Boukhouna; Amélie Geffray; Marie-Noëlle Guerrault; François Bordet; Denis Brossard
Journal:  Eur J Pediatr       Date:  2006-04-19       Impact factor: 3.183

3.  Review of data of the patients receiving total parenteral nutrition at the intensive care unit of a university hospital.

Authors:  Nimet Ovayolu; Seda Torun; Ozlem Ucan; Perihan Ozdemir; Hakan Buyukhatipoglu; Yavuz Pehlivan; Ramazan Geyik
Journal:  J Natl Med Assoc       Date:  2006-12       Impact factor: 1.798

4.  Automated compounding of parenteral nutrition for pediatric patients: characterization of workload and costs.

Authors:  Mélina Raimbault; Maxime Thibault; Denis Lebel; Jean-François Bussières
Journal:  J Pediatr Pharmacol Ther       Date:  2012-10

Review 5.  Role of pharmacists in providing parenteral nutrition support: current insights and future directions.

Authors:  Maram Gamal Katoue
Journal:  Integr Pharm Res Pract       Date:  2018-10-02

6.  A Pre-Post Intervention-Based Study Investigating the Impact of Standardized Parenteral Nutrition at Tertiary Neonatal Intensive Care Unit in Karachi, Pakistan.

Authors:  Vikram Kumar; Anum Rahim; Erum Choudry; Rafia Jabbar; Waqar H Khowaja; Shabina Ariff; Syed Rehan Ali
Journal:  Cureus       Date:  2021-05-25

7.  Role of the pharmacist in parenteral nutrition therapy: challenges and opportunities to implement pharmaceutical care in Kuwait.

Authors:  Maram G Katoue; Dalal Al-Taweel
Journal:  Pharm Pract (Granada)       Date:  2016-06-15

8.  Parenteral Nutrition Process Management for Newborn and Preterm Infants - A Preliminary Risk Analysis.

Authors:  Isabelle Sommer; David Palmero; Céline Julie Fischer Fumeaux; Pascal Bonnabry; Lucie Bouchoud; Farshid Sadeghipour
Journal:  Ther Clin Risk Manag       Date:  2021-05-28       Impact factor: 2.423

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.